- Brenntag’s 1Q EPS was EU0.97, falling short of the estimated EU1.03.
- Sales were reported at EU4.00 billion, which was less than the predicted EU4.26 billion.
- Brenntag’s stocks are currently rated as: 9 buys, 11 holds, 3 sells.
A look at Brenntag AG Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 4 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Analysts have assessed Brenntag AG‘s long-term outlook using the Smartkarma Smart Scores system. With a solid score in Dividend and Growth factors at 4 each, the company is perceived favorably in terms of its ability to generate dividends for investors and potential for future growth. Additionally, Brenntag AG has received a respectable score of 3 in Value, indicating that the company’s stock may be reasonably priced relative to its fundamental value. This suggests a promising financial standing for the industrial and specialty chemicals distributor.
Despite having average scores in Resilience and Momentum at 3, Brenntag AG remains positioned decently in terms of its ability to withstand economic challenges and its current market momentum. Overall, with a diverse customer base that includes oil and gas, paint, cosmetic, pharmaceutical, and water treatment companies, Brenntag AG seems well-positioned for long-term success in the chemical distribution industry.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
